PWMG
IOVA icon

Private Wealth Management Group’s Iovance Biotherapeutics IOVA Stock Holding History

Private Wealth Management Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-463
Closed -$1.54K – 1542
2025
Q1 		$1.54K Hold
463
– – ﹤0.01% 1145
2024
Q4 		$3.43K Hold
463
– – ﹤0.01% 896
2024
Q3 		$4.35K Hold
463
– – ﹤0.01% 784
2024
Q2 		$3.71K Hold
463
– – ﹤0.01% 827
2024
Q1 		$6.86K Hold
463
– – ﹤0.01% 524
2023
Q4 		$3.77K Buy
+463
New +$2.42K ﹤0.01% 726

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Wealth Management Group's IOVA Position: Q2 2025 in Review

Private Wealth Management Group sold out of Iovance Biotherapeutics (IOVA) in Q2 2025, closing a stake of 463 shares — an estimated $1.54K sold.

Private Wealth Management Group first reported a position in IOVA in Q4 2023 and held it in 6 quarters. The position peaked at $6.86K in Q1 2024. 254 funds tracked by Wall St. Rank hold IOVA as of Q2 2025.

  • Private Wealth Management Group reported no remaining Iovance Biotherapeutics position as of Q2 2025 after selling out during the quarter.
  • Private Wealth Management Group sold 463 Iovance Biotherapeutics shares in Q2 2025, an estimated $1.54K.
  • Private Wealth Management Group first reported a position in Iovance Biotherapeutics in Q4 2023 and held it in 6 quarters.
  • Private Wealth Management Group's Iovance Biotherapeutics position peaked at $6.86K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2025.

Based on Private Wealth Management Group's 13F filing for Q2 2025, filed 29 Jul 2025.